Phenotyping Heart Failure With Preserved Ejection Fraction in Japan ― Position Paper on Current Evidence and Future Directions ―
Abstract
Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in Japan in parallel with population aging, rising from just over half of all heart failure cases in 2015 to approximately 54% in 2025 and projected to reach nearly 57% by 2040-2050. HFpEF is a multifactorial syndrome shaped by diverse clinical and pathophysiological drivers. In East Asia, where obesity is less prevalent than in Western countries, the relative contribution of these different drivers may differ, underscoring the need for region-specific phenotypic characterization. In recent years, multiple Japanese registries have reported machine learning-based phenotyping analyses in HFpEF, identifying broadly similar but not identical patient clusters. In this position paper, we provide an integrative overview of major Japanese HFpEF cohorts and synthesize these findings to propose a pragmatic consensus framework for interpreting HFpEF heterogeneity in Japan. Despite methodological differences across cohorts, several clinical domains consistently emerged, including atrial remodeling/atrial fibrillation, vascular-cardiorenal dysfunction, metabolic burden, and systemic vulnerability. Based on these shared features, we propose 4 consensus phenogroups: (1) low structural and comorbidity burden; (2) vascular and cardiorenal remodeling; (3) atrial remodeling with right heart dysfunction; and (4) systemic vulnerability. This framework may support interpretation of HFpEF heterogeneity and guide future phenotype-informed research.
Related
- Machine-learning phenotyping and exploratory medication-outcome associations in heart failure with preserved ejection fraction: a multicohort retrospective study
- Artificial intelligence-enabled deep clinical phenotyping in heart failure with preserved ejection fraction: from patient subtypes to precision care.
- Routine cine cardiovascular magnetic resonance for clinical phenotyping and serial assessment of heart failure with preserved ejection fraction: a retrospective single-center clinical analysis
- Presumed right atrial myxoma causing mechanical inflow obstruction and a heart-failure-with-preserved-ejection-fraction–mimicking phenotype in a resource-limited setting: A case report
- Neutrophil-to-Lymphocyte Ratio Identifies a Pulmonary Vascular High-Risk Phenotype in Heart Failure with Preserved Ejection Fraction
BibTeX
@article{sakata2026phenotyping,
title = {{Phenotyping Heart Failure With Preserved Ejection Fraction in Japan ― Position Paper on Current Evidence and Future Directions ―}},
author = {Yasushi Sakata and Yuki Matsuoka and Kotaro Nochioka and Atsushi Kyodo and Shun Kohsaka and Masaru Obokata and Toshiyuki Nagai and Toshihisa Anzai and Tomohito Ohtani and Yoshio Yasumura and Katsuki Okada and Yohei Sotomi and Shungo Hikoso},
journal = {Circulation Journal},
year = {2026},
month = oct,
doi = {10.1253/circj.cj-26-0356},
url = {https://www.jstage.jst.go.jp/article/circj/90/11/90_CJ-26-0356/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Phenotyping Heart Failure With Preserved Ejection Fraction in Japan ― Position Paper on Current Evidence and Future Directions ―
AU - Yasushi Sakata
AU - Yuki Matsuoka
AU - Kotaro Nochioka
AU - Atsushi Kyodo
AU - Shun Kohsaka
AU - Masaru Obokata
AU - Toshiyuki Nagai
AU - Toshihisa Anzai
AU - Tomohito Ohtani
AU - Yoshio Yasumura
AU - Katsuki Okada
AU - Yohei Sotomi
AU - Shungo Hikoso
PY - 2026
DA - 2026/10/23
JO - Circulation Journal
DO - 10.1253/circj.cj-26-0356
UR - https://www.jstage.jst.go.jp/article/circj/90/11/90_CJ-26-0356/_article
AB - Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in Japan in parallel with population aging, rising from just over half of all heart failure cases in 2015 to approximately 54% in 2025 and projected to reach nearly 57% by 2040-2050. HFpEF is a multifactorial syndrome shaped by diverse clinical and pathophysiological drivers. In East Asia, where obesity is less prevalent than in Western countries, the relative contribution of these different drivers may differ, underscoring the need for region-specific phenotypic characterization. In recent years, multiple Japanese registries have reported machine learning-based phenotyping analyses in HFpEF, identifying broadly similar but not identical patient clusters. In this position paper, we provide an integrative overview of major Japanese HFpEF cohorts and synthesize these findings to propose a pragmatic consensus framework for interpreting HFpEF heterogeneity in Japan. Despite methodological differences across cohorts, several clinical domains consistently emerged, including atrial remodeling/atrial fibrillation, vascular-cardiorenal dysfunction, metabolic burden, and systemic vulnerability. Based on these shared features, we propose 4 consensus phenogroups: (1) low structural and comorbidity burden; (2) vascular and cardiorenal remodeling; (3) atrial remodeling with right heart dysfunction; and (4) systemic vulnerability. This framework may support interpretation of HFpEF heterogeneity and guide future phenotype-informed research.
SN - 1347-4820
SN - 1346-9843
ER -